JustinGregoryBrandlerMD

Gastroenterology • Seattle, WA

Anorectal Function & Pelvic Floor Dysfunction, Gastrointestinal Functional & Motility Disorders

Twitter: @jbrandlerMD

Join to view full profile

Dr. Brandler is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Brandler's full profile

Already have an account?

Office
1100 9th Ave
Stop C3-GAS
Seattle, WA 98101
Phone+1 206-223-2319

Fax+1 206-341-1405

Summary

Interested in neurogastroenterology and motility disorders (IBS and its friends), pelvic floor disorders. I specialize in thinking holistically, patient and provider empowerment, and using innovative healthcare delivery via integrated compassionate care to drive high value, low cost care to improve quality of life.

Education & Training

University of MichiganFellowship, Gastroenterology, 2022
University of Michigan Medical CenterGastroenterology, 2022
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2015 - 2018
University of Washington School of MedicineClass of 2015

Certifications & Licensure

WA State Medical License 2022 - 2026
MI State Medical License 2020 - 2023
MN State Medical License 2016 - 2019
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Gastroenterology

Publications & Presentations

PubMed

19 citations
Impact of Bile Acid Diarrhea in Patients With Diarrhea-Predominant Irritable Bowel Syndrome on Symptoms and Quality of Life.
Joelle BouSaba, Wassel Sannaa, Sanna McKinzie, Priya Vijayvargiya, Victor Chedid
Clinical Gastroenterology and Hepatology. 2022-09-01
1 citations
A Case of Recurrent Hepatic Abscesses.
Jessica L. Sheehan, Justin Brandler, Michael D. Rice
Gastroenterology. 2021-04-08
22 citations
Randomised study: effects of the 5-HT4 receptor agonist felcisetrag vs placebo on gut transit in patients with gastroparesis
Victor Chedid, Justin Brandler, Kayla Arndt, Priya Vijayvargiya, Xiao Jing Wang
Alimentary Pharmacology & Therapeutics. 2021-03-12

Authored Content

My Failure to Match Made Me a Better DoctorNovember 2019

Press Mentions

Randomised Study: Effects of the 5‐HT4 Receptor Agonist Felcisetrag vs Placebo on Gut Transit in Patients with GastroparesisMarch 12th, 2021
Cannabis, Probiotics and More: What Works Best for IBS?October 23rd, 2020

Professional Memberships